Clinical Trials for Acute Myeloid Leukemia

Find clinical trials for acute myeloid leukemia. Discover research opportunities and treatment options in your area.

354 Active Trials Found

Showing 354 trials on this page

Page 17 of 18

CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

NCT ID: NCT04257175

This clinical trial is investigating a new treatment for patients with a type of blood cancer called acute myeloid leukemia (AML) who have not responded to standard therapies or whose cancer has co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ramat Gan, Israel

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

NCT ID: NCT05918198

This clinical trial is studying a new treatment approach for patients with acute myeloid leukemia (AML) that has either come back after treatment or did not respond to previous therapies. The resea...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

NCT ID: NCT06133556

This clinical trial is investigating a new treatment approach for patients with Acute Myeloid Leukemia (AML) that has not responded to previous treatments or has come back after treatment. Specific...

Not yet recruiting

Phase: PHASE2 Type: interventional

Universal CAR-T Cells Targeting AML

NCT ID: NCT05995041

This clinical trial is studying a new treatment for patients with Acute Myeloid Leukemia (AML) called universal CAR-T cells. These cells are designed to target specific markers in the leukemia cell...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenzhen, Guangdong, China, Haikou, Hainan, China +1 more

Universal 4SCAR7U Targeting CD7-positive Malignancies

NCT ID: NCT05995028

This clinical trial is studying a new type of treatment called universal CAR T cells, specifically designed to target a protein known as CD7 found on certain types of blood cancers, including T-cel...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenzhen, Guangdong, China, Haikou, Hainan, China +1 more

Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients

NCT ID: NCT06073730

This clinical trial is studying the effectiveness and safety of a new treatment for older patients or those who are not fit for standard chemotherapy and have just been diagnosed with acute myeloid...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Kunming, Yunnan, China

Methods of T Cell Depletion Trial (MoTD)

NCT ID: NCT04888741

The Methods of T Cell Depletion Trial (MoTD) is a research study designed to improve the safety of stem cell transplants for patients with certain blood cancers, like acute myeloid leukemia and mul...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, United Kingdom, Nottingham, United Kingdom +13 more

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

NCT ID: NCT05801835

This clinical trial is studying a new treatment called (cytarabine: daunorubicin) liposome for injection to see if it works the same way as an existing treatment known as Vyxeos in older adults wit...

Recruiting

Phase: NA Type: interventional Locations: Tianjin, China

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

NCT ID: NCT04671693

This clinical trial is studying how to identify and manage health issues that may arise after cancer treatments in survivors. Many cancer survivors experience new health problems years after their ...

Recruiting

Phase: NA Type: interventional Locations: Lyon, France

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT ID: NCT06006403

This clinical trial is exploring a new treatment for patients with relapsed or refractory acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN). The treatment involv...

Recruiting

Phase: PHASE1 Type: interventional Locations: Taiyuan, Shanxi, China

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

NCT ID: NCT05983172

This study is a large, observational project aiming to improve how doctors predict outcomes for adults with new acute myeloid leukemia (AML). Researchers will combine several types of information—w...

Enrolling by invitation

Type: observational Locations: Taipei, Taiwan, Taipei, Taiwan

Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

NCT ID: NCT04385290

The MOSAIC trial is a research study looking at the safety and effectiveness of two drugs, midostaurin and gemtuzumab ozogamicin, when used together as a first treatment for patients with newly dia...

Recruiting

Phase: PHASE1 Type: interventional Locations: Stuttgart, Germany, Mannheim, Germany +21 more

Acute Myeloid Leukemia Registry

NCT ID: NCT05979675

The Acute Myeloid Leukemia Registry is a clinical trial that aims to gather information about patients diagnosed with acute myeloid leukemia (AML) after January 1, 2020. This study is currently loo...

Recruiting

Type: observational Locations: Antalya, Turkey

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

NCT ID: NCT05909293

This clinical trial is studying a treatment called maintenance therapy with a medication known as Venetoclax for elderly patients with acute myeloid leukemia (AML) who have achieved their first com...

Recruiting

Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China

Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia

NCT ID: NCT05893329

This clinical trial is investigating a new treatment for patients with acute myeloid leukemia (AML) who have not received any treatment before. The study aims to see how safe and effective a combin...

Not yet recruiting

Phase: Not Applicable Type: interventional

RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

NCT ID: NCT05858814

This clinical trial is studying a treatment called RC1012 injection, which is made from specialized immune cells. The goal is to see if this treatment can help prevent patients with Acute Myeloid L...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hefei, Anhui, China

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

NCT ID: NCT05823714

This clinical trial is studying a new treatment combination for patients with high-risk acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) who are preparing for a bone marrow transpla...

Recruiting

Phase: PHASE2 Type: interventional Locations: Suzhou, Jiangsu, China, Suzhou, Jiangsu, China

Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML

NCT ID: NCT05805098

This clinical trial is studying a combination of three medications—venetoclax, homoharringtonine, and cytarabine—to find out how effective and safe they are for treating newly diagnosed acute myelo...

Recruiting

Phase: PHASE2 Type: interventional Locations: Suzhou, Jiangsu, China

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

NCT ID: NCT04913922

This clinical trial is studying a new combination treatment for patients with Acute Myeloid Leukemia (AML). The treatment includes a medication called azacitidine along with two immune system boost...

Recruiting

Phase: PHASE2 Type: interventional Locations: Munich, Germany

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

NCT ID: NCT05445011

This clinical trial is testing a new treatment called Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) for patients with acute myeloid leukemia (AML) that has come back or has not responded to previous ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions